| 1 | CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility | 3.8 | 17 | Citations (PDF) |
| 2 | Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies | 1.1 | 10 | Citations (PDF) |
| 3 | Accounting for
EGFR
Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data | 1.1 | 2 | Citations (PDF) |
| 4 | Rare germline copy number variants (CNVs) and breast cancer risk | 4.4 | 14 | Citations (PDF) |
| 5 | Gene–gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer | 3.0 | 3 | Citations (PDF) |
| 6 | Common variants in breast cancer risk loci predispose to distinct tumor subtypes | 4.7 | 28 | Citations (PDF) |
| 7 | Iam hiQ—a novel pair of accuracy indices for imputed genotypes | 3.0 | 4 | Citations (PDF) |
| 8 | Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer | 25.2 | 113 | Citations (PDF) |
| 9 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model | 4.9 | 20 | Citations (PDF) |
| 10 | Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk | 4.6 | 56 | Citations (PDF) |
| 11 | Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization | 4.3 | 151 | Citations (PDF) |
| 12 | CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers | 5.5 | 8 | Citations (PDF) |
| 13 | The utility of the Laplace effect size prior distribution in Bayesian fine‐mapping studies | 3.1 | 4 | Citations (PDF) |
| 14 | Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? | 3.8 | 8 | Citations (PDF) |
| 15 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element | 6.5 | 7 | Citations (PDF) |
| 16 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment | 4.7 | 21 | Citations (PDF) |
| 17 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk | 5.5 | 21 | Citations (PDF) |
| 18 | Genetic insights into biological mechanisms governing human ovarian ageing | 37.9 | 381 | Citations (PDF) |
| 19 | Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium | 1.1 | 38 | Citations (PDF) |
| 20 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes | 25.2 | 171 | Citations (PDF) |
| 21 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk | 6.5 | 61 | Citations (PDF) |
| 22 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses | 25.2 | 471 | Citations (PDF) |
| 23 | Protein-altering germline mutations implicate novel genes related to lung cancer development | 13.7 | 44 | Citations (PDF) |
| 24 | Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status | 3.1 | 43 | Citations (PDF) |
| 25 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis | 13.7 | 36 | Citations (PDF) |
| 26 | Using GWAS top hits to inform priors in Bayesian fine‐mapping association studies | 3.1 | 10 | Citations (PDF) |
| 27 | Bayesian variable selection using partially observed categorical prior information in fine‐mapping association studies | 3.1 | 8 | Citations (PDF) |
| 28 | Shared heritability and functional enrichment across six solid cancers | 13.7 | 108 | Citations (PDF) |
| 29 | Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis | 1.1 | 27 | Citations (PDF) |
| 30 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer | 13.7 | 118 | Citations (PDF) |
| 31 | Genome-wide association study of germline variants and breast cancer-specific mortality | 5.5 | 62 | Citations (PDF) |
| 32 | Assessing melanoma BRAF status through ddPCR of cfDNA | 9.9 | 1 | Citations (PDF) |
| 33 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes | 6.5 | 1,034 | Citations (PDF) |
| 34 | Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphomaBlood, 2019, 133, 1130-1139 | 4.8 | 39 | Citations (PDF) |
| 35 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis | 4.9 | 95 | Citations (PDF) |
| 36 | The BRCA2
c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity | 4.5 | 20 | Citations (PDF) |
| 37 | Genetic overlap between endometriosis and endometrial cancer: evidence from cross‐disease genetic correlation and GWAS meta‐analyses | 2.6 | 80 | Citations (PDF) |
| 38 | Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population | 2.8 | 33 | Citations (PDF) |
| 39 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium | 4.9 | 96 | Citations (PDF) |
| 40 | Genome-Wide Analysis of Circulating Cell-Free DNA Copy Number Detects Active Melanoma and Predicts Survival | 1.1 | 11 | Citations (PDF) |
| 41 | Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing | 4.6 | 291 | Citations (PDF) |
| 42 | Plasma cell depletion with bortezomib in the treatment of refractory N‐methyl‐d‐aspartate (NMDA) receptor antibody encephalitis. Rational developments in neuroimmunological treatment | 3.5 | 34 | Citations (PDF) |
| 43 | Identification of nine new susceptibility loci for endometrial cancer | 13.7 | 277 | Citations (PDF) |
| 44 | Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk | 13.7 | 75 | Citations (PDF) |
| 45 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer | 25.2 | 230 | Citations (PDF) |
| 46 | BRCA2
Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer | 3.8 | 90 | Citations (PDF) |
| 47 | Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk | 25.2 | 534 | Citations (PDF) |
| 48 | Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes | 25.2 | 716 | Citations (PDF) |
| 49 | Association analysis identifies 65 new breast cancer risk loci | 37.9 | 1,431 | Citations (PDF) |
| 50 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer | 25.2 | 405 | Citations (PDF) |
| 51 | Gene–environment interactions involving functional variants: Results from the Breast Cancer Association Consortium | 4.3 | 22 | Citations (PDF) |
| 52 | Copy-number profiles from circulating cell-free DNA as a potential biomarker in melanoma | 0.9 | 0 | Citations (PDF) |
| 53 | Body mass index and breast cancer survival: a Mendelian randomization analysis | 4.9 | 57 | Citations (PDF) |
| 54 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study | 4.7 | 46 | Citations (PDF) |
| 55 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent | 8.0 | 139 | Citations (PDF) |
| 56 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus | 2.3 | 12 | Citations (PDF) |
| 57 | Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment | 2.3 | 23 | Citations (PDF) |
| 58 | Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus | 3.8 | 13 | Citations (PDF) |
| 59 | Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer | 4.3 | 54 | Citations (PDF) |
| 60 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS | 3.8 | 208 | Citations (PDF) |
| 61 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus | 4.7 | 37 | Citations (PDF) |
| 62 | Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes | 2.3 | 20 | Citations (PDF) |
| 63 | Genetic predisposition to ductal carcinoma in situ of the breast | 4.7 | 54 | Citations (PDF) |
| 64 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry | 1.7 | 24 | Citations (PDF) |
| 65 | Five endometrial cancer risk loci identified through genome-wide association analysis | 25.2 | 94 | Citations (PDF) |
| 66 | Incorporating Functional Genomic Information in Genetic Association Studies Using an Empirical Bayes Approach | 3.1 | 14 | Citations (PDF) |
| 67 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression | 2.9 | 34 | Citations (PDF) |
| 68 | Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer | 1.1 | 81 | Citations (PDF) |
| 69 | Circulating cell-free DNA copy-number profiles as a biomarker in melanoma | 0.9 | 0 | Citations (PDF) |
| 70 | rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk | 3.4 | 2 | Citations (PDF) |
| 71 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types | 25.1 | 192 | Citations (PDF) |
| 72 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer | 13.7 | 103 | Citations (PDF) |
| 73 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus | 13.7 | 90 | Citations (PDF) |
| 74 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs) | 3.4 | 21 | Citations (PDF) |
| 75 | Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia | 13.7 | 113 | Citations (PDF) |
| 76 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing | 3.8 | 102 | Citations (PDF) |
| 77 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 | 25.2 | 150 | Citations (PDF) |
| 78 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers | 4.6 | 82 | Citations (PDF) |
| 79 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer | 3.0 | 20 | Citations (PDF) |
| 80 | RAD51B in Familial Breast Cancer | 2.3 | 29 | Citations (PDF) |
| 81 | Levels of DNA Methylation Vary at CpG Sites across the BRCA1 Promoter, and Differ According to Triple Negative and “BRCA-Like” Status, in Both Blood and Tumour DNA | 2.3 | 19 | Citations (PDF) |
| 82 | Novel Bayes Factors That Capture Expert Uncertainty in Prior Density Specification in Genetic Association Studies | 3.1 | 10 | Citations (PDF) |
| 83 | Investigation of gene‐environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors | 4.3 | 37 | Citations (PDF) |
| 84 | Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1 | 3.4 | 41 | Citations (PDF) |
| 85 | Common germline polymorphisms associated with breast cancer-specific survival | 4.7 | 29 | Citations (PDF) |
| 86 | Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants | 4.6 | 486 | Citations (PDF) |
| 87 | Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium | 3.3 | 26 | Citations (PDF) |
| 88 | Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer | 9.7 | 59 | Citations (PDF) |
| 89 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2 | 2.9 | 41 | Citations (PDF) |
| 90 | Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1 | 6.5 | 84 | Citations (PDF) |
| 91 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer | 2.8 | 18 | Citations (PDF) |
| 92 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer | 25.2 | 584 | Citations (PDF) |
| 93 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression | 6.5 | 40 | Citations (PDF) |
| 94 | Identification of Novel Genetic Markers of Breast Cancer Survival | 4.6 | 65 | Citations (PDF) |
| 95 | Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci | 1.1 | 59 | Citations (PDF) |
| 96 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair | 25.2 | 427 | Citations (PDF) |
| 97 | Contemporary Occupational Carcinogen Exposure and Bladder Cancer | 14.3 | 231 | Citations (PDF) |
| 98 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization | 4.6 | 114 | Citations (PDF) |
| 99 | Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk | 1.1 | 26 | Citations (PDF) |
| 100 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk | 2.9 | 40 | Citations (PDF) |
| 101 | Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk | 2.9 | 54 | Citations (PDF) |
| 102 | Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers | 5.5 | 9 | Citations (PDF) |
| 103 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium | 2.9 | 10 | Citations (PDF) |
| 104 | Patient-Reported Outcomes (PRO) in the Setting of Relapsed Myeloma: The Influence of Treatment Strategies and Genetic Variants Predict Quality of Life and Pain ExperienceBlood, 2015, 126, 3180-3180 | 4.8 | 0 | Citations (PDF) |
| 105 | MicroRNA Related Polymorphisms and Breast Cancer Risk | 2.3 | 52 | Citations (PDF) |
| 106 | Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast | 3.2 | 45 | Citations (PDF) |
| 107 | Comparing the Efficacy of SNP Filtering Methods for Identifying a Single Causal SNP in a Known Association Region | 1.1 | 15 | Citations (PDF) |
| 108 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium | 2.9 | 58 | Citations (PDF) |
| 109 | Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia | 4.7 | 111 | Citations (PDF) |
| 110 | DNA mismatch repair gene MSH6 implicated in determining age at natural menopause | 2.9 | 67 | Citations (PDF) |
| 111 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium | 2.9 | 34 | Citations (PDF) |
| 112 | Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions | 3.1 | 28 | Citations (PDF) |
| 113 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer | 2.8 | 161 | Citations (PDF) |
| 114 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche | 37.9 | 627 | Citations (PDF) |
| 115 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation | 13.7 | 110 | Citations (PDF) |
| 116 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade | 2.9 | 14 | Citations (PDF) |
| 117 | Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk | 2.9 | 35 | Citations (PDF) |
| 118 | The common PARK8 mutation LRRK2 G2019S is not a risk factor for breast cancer in the absence of Parkinson’s disease | 3.4 | 5 | Citations (PDF) |
| 119 | Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1 | 6.5 | 105 | Citations (PDF) |
| 120 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer | 25.2 | 523 | Citations (PDF) |
| 121 | Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer | 4.7 | 363 | Citations (PDF) |
| 122 | Very Low PSA Concentrations and Deletions of the KLK3 Gene | 1.1 | 14 | Citations (PDF) |
| 123 | Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers | 6.5 | 209 | Citations (PDF) |
| 124 | Genome-wide association studies identify four ER negative–specific breast cancer risk loci | 25.2 | 402 | Citations (PDF) |
| 125 | Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array | 25.2 | 518 | Citations (PDF) |
| 126 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk | 25.2 | 1,027 | Citations (PDF) |
| 127 | Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia | 25.2 | 207 | Citations (PDF) |
| 128 | A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease | 2.9 | 124 | Citations (PDF) |
| 129 | Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk | 3.2 | 115 | Citations (PDF) |
| 130 | Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors | 3.2 | 144 | Citations (PDF) |
| 131 | Circulating Cell-Free DNA: A Potential Biomarker in Lung Cancer | 0.6 | 0 | Citations (PDF) |
| 132 | Identification of Candidate Driver Genes in Common Focal Chromosomal Aberrations of Microsatellite Stable Colorectal Cancer | 2.3 | 35 | Citations (PDF) |
| 133 | Associations of ATR and CHEK1 Single Nucleotide Polymorphisms with Breast Cancer | 2.3 | 15 | Citations (PDF) |
| 134 | 19p13.1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus | 3.8 | 105 | Citations (PDF) |
| 135 | Fine-Mapping
CASP8
Risk Variants in Breast Cancer | 1.1 | 23 | Citations (PDF) |
| 136 | The role of genetic breast cancer susceptibility variants as prognostic factors | 2.9 | 85 | Citations (PDF) |
| 137 | Genome-wide association analysis identifies three new breast cancer susceptibility loci | 25.2 | 272 | Citations (PDF) |
| 138 | Lack of association between polymorphisms in the interleukin-1 gene cluster and familial thrombophilia | 2.3 | 0 | Citations (PDF) |
| 139 | 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium | 1.1 | 17 | Citations (PDF) |
| 140 | 1. Hypermethylation of distinct CpG islands within the BRCA1 promoter is associated with triple negative phenotype breast cancer | 0.9 | 0 | Citations (PDF) |
| 141 | A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients | 1.4 | 12 | Citations (PDF) |
| 142 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11 | 2.9 | 173 | Citations (PDF) |
| 143 | Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 | 2.3 | 12 | Citations (PDF) |
| 144 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer | 4.5 | 36 | Citations (PDF) |
| 145 | Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) | 2.3 | 52 | Citations (PDF) |
| 146 | Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer | 1.1 | 27 | Citations (PDF) |
| 147 | Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies | 4.6 | 630 | Citations (PDF) |
| 148 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium | 2.9 | 156 | Citations (PDF) |
| 149 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer | 25.2 | 298 | Citations (PDF) |
| 150 | A role for XRCC2 gene polymorphisms in breast cancer risk and survival | 3.8 | 49 | Citations (PDF) |
| 151 | Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study | 25.2 | 278 | Citations (PDF) |
| 152 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium† | 2.9 | 73 | Citations (PDF) |
| 153 | 7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium | 3.8 | 5 | Citations (PDF) |
| 154 | Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer | 3.8 | 115 | Citations (PDF) |
| 155 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study | 4.7 | 86 | Citations (PDF) |
| 156 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population | 25.2 | 318 | Citations (PDF) |
| 157 | Associations of Folate, Vitamin B12, Homocysteine, and Folate-Pathway Polymorphisms with Prostate-Specific Antigen Velocity in Men with Localized Prostate Cancer | 1.1 | 23 | Citations (PDF) |
| 158 | Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls | 1.1 | 36 | Citations (PDF) |
| 159 | Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies | 8.0 | 834 | Citations (PDF) |
| 160 | Association Between a Germline OCA2 Polymorphism at Chromosome 15q13.1 and Estrogen Receptor–Negative Breast Cancer Survival | 4.6 | 52 | Citations (PDF) |
| 161 | Associations between an Obesity Related Genetic Variant (FTO rs9939609) and Prostate Cancer Risk | 2.3 | 64 | Citations (PDF) |
| 162 | Genetic Variants in
XRCC2
: New Insights Into Colorectal Cancer Tumorigenesis | 1.1 | 39 | Citations (PDF) |
| 163 | Risk of Estrogen Receptor–Positive and –Negative Breast Cancer and Single–Nucleotide Polymorphism 2q35-rs13387042 | 4.6 | 101 | Citations (PDF) |
| 164 | Genetic Variants in the Vitamin D Receptor Are Associated with Advanced Prostate Cancer at Diagnosis: Findings from the Prostate Testing for Cancer and Treatment Study and a Systematic Review | 1.1 | 66 | Citations (PDF) |
| 165 | Association of Folate-Pathway Gene Polymorphisms with the Risk of Prostate Cancer: a Population-Based Nested Case-Control Study, Systematic Review, and Meta-analysis | 1.1 | 93 | Citations (PDF) |
| 166 | Identification of new genetic risk factors for prostate cancer | 1.9 | 25 | Citations (PDF) |
| 167 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 | 25.2 | 447 | Citations (PDF) |
| 168 | Identification of seven new prostate cancer susceptibility loci through a genome-wide association study | 25.2 | 403 | Citations (PDF) |
| 169 | Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium | 1.1 | 59 | Citations (PDF) |
| 170 | Evaluation of the current knowledge limitations in breast cancer research: a gap analysis | 4.7 | 96 | Citations (PDF) |
| 171 | hapConstructor: automatic construction and testing of haplotypes in a Monte Carlo framework | 4.7 | 17 | Citations (PDF) |
| 172 | Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL Consortium | 1.1 | 151 | Citations (PDF) |
| 173 | Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics | 3.2 | 325 | Citations (PDF) |
| 174 | A common coding variant in CASP8 is associated with breast cancer risk | 25.2 | 603 | Citations (PDF) |
| 175 | Genome-wide association study identifies novel breast cancer susceptibility loci | 37.9 | 2,218 | Citations (PDF) |
| 176 | Endostatin gene variation and protein levels in breast cancer susceptibility and severity | 2.9 | 21 | Citations (PDF) |
| 177 | Combination of Polymorphisms From Genes Related to Estrogen Metabolism and Risk of Prostate Cancers: The Hidden Face of Estrogens | 16.9 | 90 | Citations (PDF) |
| 178 | The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study | 2.3 | 50 | Citations (PDF) |
| 179 | Mitotic defects in XRCC3 variants T241M and D213N and their relation to cancer susceptibility | 2.9 | 37 | Citations (PDF) |
| 180 | The window of therapeutic opportunity in multiple sclerosis | 3.4 | 493 | Citations (PDF) |
| 181 | Association of a Common Variant of the CASP8 Gene With Reduced Risk of Breast Cancer | 4.6 | 194 | Citations (PDF) |
| 182 | Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity | 4.7 | 67 | Citations (PDF) |
| 183 | A naturally occurring mutation in an ATP-binding domain of the recombination repair gene XRCC3 ablates its function without causing cancer susceptibility | 2.9 | 13 | Citations (PDF) |
| 184 | A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer | 2.9 | 107 | Citations (PDF) |
| 185 | The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis | 0.9 | 130 | Citations (PDF) |
| 186 | Association of interleukin-1α and interleukin-1β gene alleles with ulcerative colitis: Evidence for genetic susceptibility | 0.9 | 0 | Citations (PDF) |
| 187 | Association analysis of IL1A and IL1B variants in alopecia areata | 3.2 | 20 | Citations (PDF) |
| 188 | Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region | 2.9 | 58 | Citations (PDF) |
| 189 | An Analysis of Linkage Disequilibrium in the Interleukin-1 Gene Cluster, Using a Novel Grouping Method for Multiallelic Markers | 6.5 | 179 | Citations (PDF) |
| 190 | The Human Gene Encoding the Interleukin-1 Receptor Accessory Protein (IL1RAP) Maps to Chromosome 3q28 by Fluorescencein SituHybridization and Radiation Hybrid Mapping | 2.8 | 13 | Citations (PDF) |
| 191 | Molecular Cloning of the Interleukin-1 Gene Cluster: Construction of an Integrated YAC/PAC Contig and a Partial Transcriptional Map in the Region of Chromosome 2q13 | 2.8 | 45 | Citations (PDF) |
| 192 | Interleukin-1 receptor antagonist allele (ILIRN*2) associated with nephropathy in diabetes mellitus | 2.9 | 146 | Citations (PDF) |
| 193 | Ultrabithorax mutations map to distant sites within the bithorax complex of Drosophila | 37.9 | 18 | Citations (PDF) |
